CorporateSanofi Calls Report of Insulin Brand Divestment "Unfounded, Incorrect"BY Outlook Business Desk
NewsGlenmark Inks Licensing Pact With Jiangsu Alphamab, 3D Medicines For Cancer DrugBY Press Trust of India